News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
466,356 Results
Type
Article (17777)
Company Profile (79)
Press Release (448500)
Multimedia
Podcasts (28)
Webinars (4)
Section
Business (139948)
Career Advice (721)
Deals (26044)
Drug Delivery (81)
Drug Development (55876)
Employer Resources (78)
FDA (13372)
Job Trends (9940)
News (241112)
Policy (23277)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (893)
Accelerated approval (3)
Adcomms (12)
Allergies (67)
Alliances (36416)
ALS (48)
Alzheimer's disease (761)
Antibody-drug conjugate (ADC) (68)
Approvals (13431)
Artificial intelligence (140)
Autoimmune disease (16)
Automation (13)
Bankruptcy (210)
Best Places to Work (8078)
BIOSECURE Act (13)
Biosimilars (96)
Biotechnology (51)
Bladder cancer (47)
Brain cancer (13)
Breast cancer (133)
Cancer (1349)
Cardiovascular disease (102)
Career advice (618)
Career pathing (9)
CAR-T (120)
Cell therapy (341)
Cervical cancer (14)
Clinical research (46699)
Collaboration (581)
Compensation (223)
Complete response letters (14)
COVID-19 (1454)
CRISPR (25)
C-suite (154)
Cystic fibrosis (58)
Data (1561)
Denatured (14)
Depression (23)
Diabetes (212)
Diagnostics (4288)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (71)
Drug pricing (63)
Drug shortages (26)
Duchenne muscular dystrophy (65)
Earnings (60303)
Editorial (19)
Employer branding (8)
Employer resources (63)
Events (66479)
Executive appointments (496)
FDA (14387)
Featured Employer (23)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (411)
Gene editing (67)
Generative AI (11)
Gene therapy (231)
GLP-1 (478)
Government (2796)
Grass and pollen (5)
Guidances (45)
Healthcare (10661)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (62)
Indications (25)
Infectious disease (1549)
Inflammatory bowel disease (76)
Inflation Reduction Act (6)
Influenza (43)
Intellectual property (71)
Interviews (97)
IPO (11805)
IRA (28)
Job creations (2208)
Job search strategy (546)
Kidney cancer (8)
Labor market (15)
Layoffs (270)
Leadership (7)
Legal (4657)
Liver cancer (46)
Lung cancer (201)
Lymphoma (105)
Machine learning (4)
Management (39)
Manufacturing (303)
MASH (39)
Medical device (10649)
Medtech (10653)
Mergers & acquisitions (14671)
Metabolic disorders (470)
Multiple sclerosis (57)
NASH (8)
Neurodegenerative disease (46)
Neuropsychiatric disorders (9)
Neuroscience (1073)
NextGen: Class of 2025 (3581)
Non-profit (1192)
Northern California (1752)
Now hiring (12)
Obesity (236)
Opinion (129)
Ovarian cancer (41)
Pain (53)
Pancreatic cancer (50)
Parkinson's disease (89)
Partnered (11)
Patents (179)
Patient recruitment (70)
Peanut (36)
People (37386)
Pharmaceutical (33)
Pharmacy benefit managers (6)
Phase I (14081)
Phase II (20351)
Phase III (16175)
Pipeline (968)
Policy (82)
Postmarket research (1549)
Preclinical (5410)
Press Release (67)
Prostate cancer (70)
Psychedelics (14)
Radiopharmaceuticals (176)
Rare diseases (228)
Real estate (3920)
Recruiting (29)
Regulatory (17413)
Reports (24)
Research institute (892)
Resumes & cover letters (86)
Rett syndrome (3)
RNA editing (2)
RSV (27)
Schizophrenia (40)
Series A (61)
Series B (43)
Service/supplier (8)
Sickle cell disease (34)
Southern California (1535)
Special edition (9)
Spinal muscular atrophy (112)
Sponsored (18)
Startups (2260)
State (1)
Stomach cancer (2)
Supply chain (67)
Tariffs (29)
The Weekly (14)
United States (15584)
Vaccines (403)
Venture capitalists (14)
Weight loss (159)
Women's health (22)
Worklife (9)
Date
Today (142)
Last 7 days (567)
Last 30 days (1757)
Last 365 days (22776)
2025 (7120)
2024 (24701)
2023 (28822)
2022 (38470)
2021 (41283)
2020 (39336)
2019 (30890)
2018 (23550)
2017 (24366)
2016 (22275)
2015 (26561)
2014 (19120)
2013 (15768)
2012 (17534)
2011 (18246)
2010 (16020)
Location
Africa (396)
Alabama (33)
Alaska (2)
Arizona (101)
Arkansas (9)
Asia (30249)
Australia (4864)
California (3990)
Canada (1392)
China (408)
Colorado (164)
Connecticut (179)
Delaware (97)
Europe (62517)
Florida (626)
Georgia (165)
Hawaii (1)
Idaho (37)
Illinois (365)
India (20)
Indiana (245)
Iowa (5)
Japan (122)
Kansas (83)
Kentucky (6)
Louisiana (4)
Maine (64)
Maryland (643)
Massachusetts (2845)
Michigan (205)
Minnesota (236)
Mississippi (1)
Missouri (70)
Montana (20)
Nebraska (13)
Nevada (46)
New Hampshire (49)
New Jersey (1380)
New Mexico (23)
New York (1212)
North Carolina (655)
North Dakota (6)
Northern California (1752)
Ohio (138)
Oklahoma (8)
Oregon (25)
Pennsylvania (983)
Puerto Rico (11)
Rhode Island (21)
South America (738)
South Carolina (18)
South Dakota (1)
Southern California (1535)
Tennessee (70)
Texas (545)
Utah (96)
Virginia (115)
Washington D.C. (32)
Washington State (366)
West Virginia (3)
Wisconsin (34)
466,356 Results for "artms products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
Telix Pharmaceuticals Limited announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc., its advanced cyclotron-based isotope production platform, manufacturing plant and stockpile of ultra-pure rare metals required for consumable target production.
March 4, 2024
·
11 min read
Deals
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.
April 11, 2024
·
3 min read
Press Releases
CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi® (ustekinumab-aauz)
April 29, 2025
·
11 min read
Press Releases
Telix Adds Lead-212 Isotope Production Capability
March 13, 2025
·
6 min read
ARTMS Inc. Announces Health Canada Submission for Ga-68 Production and Tri-party Collaboration to Advance Ga-68 Imaging Products
ARTMS Inc. (ARTMS), the global leader in developing and commercializing novel products enabling cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce the submission of a Type 1 Master File with the Health Products & Food Branch, Health Canada (HC) for the production of gallium-68 (Ga-68).
October 14, 2021
·
5 min read
ARTMS Inc. Produces Zirconium-89 in US Commercial Nuclear Pharmacy Using ARTMS’ QUANTM Irradiation System
ARTMS Inc. is pleased to announce the production of zirconium-89 oxalate using a low energy medical cyclotron in a US based commercial nuclear pharmacy.
December 14, 2021
·
3 min read
ARTMS Inc. Submits Drug Master File for the First Ever Multi-Curie Production of Gallium-68 with ARTMS’ Solid Target Solution on Medical Cyclotrons
ARTMS Inc. (ARTMS) is pleased to announce the submission of a Drug Master File (DMF) to the FDA for the high-volume production of Gallium-68 (68Ga) with ARTMS’ solid target technology in combination with a medical cyclotron
March 31, 2021
·
3 min read
Press Releases
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain
April 23, 2025
·
3 min read
Press Releases
NeuroPace Announces Refocusing of Product Portfolio
April 3, 2025
·
7 min read
ARTMS Inc. produces Ga-68 in US Commercial Nuclear Pharmacy using ARTMS Solid Target Technology
ARTMS Inc. is pleased to announce the production of Ga-68 Chloride using a medical cyclotron in a US based commercial nuclear pharmacy.
May 25, 2021
·
3 min read
1 of 46,636
Next
